Five new benzenoids, benzocamphorins A-E (1-5), and ten recently isolated triterpenoids, camphoratins A-J (16-25), together with 23 known compounds including seven benzenoids (6-12), three lignans (13-15), and 13 triterpenoids (26-38) were isolated from the fruiting body of Taiwanofungus camphoratus. Their structures were established by spectroscopic analysis. Selected compounds were examined for cytotoxic and anti-inflammatory activities. Compounds 9 and 21 showed moderate cytotoxicity against MCF-7 and Hep2 cell lines with ED 50 values of 3.4 and 3.0 µg/mL, respectively. Compounds 21, 25, 26, 29-31, 33, and 36 demonstrated potent antiinflammatory activity by inhibiting lipopolysaccharide (LPS)-induced nitric oxide (NO) production with IC 50 values of 2.5, 1.6, 3.6, 0.6, 4.1, 4.2, 2.5, and 1.5 µM, respectively, which were better than those of the nonspecific nitric oxide synthase (NOS) inhibitor N-nitro-L-arginine methyl ester (L-NAME) (IC 50 : 25.8 µM). These results may substantiate the use of T. camphoratus in traditional Chinese medicine (TCM) for the treatment of inflammation and cancer-
Introduction
Niu-chang-chih also named Taiwanofungus camphoratus (synonym: Ganoderma camphoratum, Antrodia cinnamomea, Antrodia camphorata) (Polyporaceae, Aphyllophorales) is a rare and precious medical fungus in Taiwan. 1 The fruiting bodies of Niu-chang-chih have been used as a Chinese folk medicine for the treatment of liver diseases, food and drug intoxication, diarrhea, abdominal pain, hypertension, itchy skin and tumorigenic diseases in Taiwan. 2, 3 Niu-chang-chih has thus received huge attention by the public. Previous studies have revealed that Niu-chang-chih exerts several biological activities, such as hepatoprotective effects, anti-hepatitis B virus effects, anticancer activity, antioxidant properties, and anti-inflammatory activities. 4, 5 Our ongoing study on the chemical constituents of an ethanol extract of the fruiting body of T. camphoratus has now led to the isolation of five new benzenoids, benzocamphorins A-E (1-5) ( Inflammation, which is related to morbidity and mortality of many diseases, is part of the complex biological response of vascular tissues to harmful stimuli, and is the host response to infection or injury, which involves the recruitment of leukocytes and the release of inflammatory mediators, including nitric oxide (NO). NO is the metabolic by-product of the conversion of L-arginine to L-citrulline by a class of enzymes termed NO synthases (NOS). Numerous cytokines can induce the transcription of inducible NO synthase (iNOS) in leukocytes, fibroblasts, and other cell types, accounting for enhanced levels of NO. Although NO is a microbicide and may have important roles in tissue adapting to inflammatory states, overproduction of NO may exacerbate tissue injury in both acute and chronic inflammatory conditions. In experimental models of acute inflammation, inhibition of iNOS can have a dose-dependent protective effect, suggesting that NO promotes edema and vascular permeability. NO also has a detrimental effect in chronic models of arthritis, whereas protection is seen with iNOS inhibitors. Glucocorticoids, which are often used in the treatment of inflammation, are able to inhibit the expression of iNOS. Therefore, the compounds isolated from T. camphoratus were tested for anti-inflammatory activity based on inhibition of NO production. In this paper, we report the structural determination of the new compounds from T. camphoratus, as well as evaluation of the cytotoxicity and antiinflammatory activity of the isolates.
Chemistry: extraction and isolation
The wild fruiting bodies of T. camphoratus, growing in Ping-Tung Hsien, Taiwan, were purchased from the Kaohsiung Society for Wildlife and Nature in June 2003. The fungus was identified by Dr. Tun-Tschu Chang. A voucher specimen (TSWu 2003005) was deposited in the Department of Chemistry, National Cheng Kung University, Tainan, Taiwan.
The fresh fruiting body of T. camphoratus (1.0 kg) was extracted with EtOH (4 × 10 L) under reflux. The EtOH extract was concentrated to afford a brown syrup (161 g) and then partitioned between MeOH/H 2 O (1:1) and n-hexane. The water layer was filtered to obtain a filtrate and a water-insoluble portion. The filtrate (55.5 g) was subjected to column chromatography on Diaion HP-20 (10 × 60 cm) using increasing concentrations of MeOH in H 2 O as the eluent to obtain ten fractions (ACEW 1-10). Compounds 11 (2.6 mg, 0.0016%) and 12 (2.2 mg, 0.0014%) were obtained from fraction ACEW 1 by silica gel column chromatography using benzene-CHCl 3 (9:1) as the eluent. Fraction ACEW 8 was rechromatographed on a silica gel column using CHCl 3 -Me 2 CO (25:1) as the eluent and purified further by preparative TLC (silica gel, i-Pr 2 O-Me 2 CO, 15:1) to obtain compounds 7 (40.0 mg, 0.025%), 4 (2.7 mg, 0.0017%), 5 (2.0 mg, 0.012%), and 6 (2.5 mg, 0.0016%). ACWE 10 was separated on a silica gel column using i-Pr 2 O-MeOH (6:1) as the eluent to afford four subfractions (ACEW10-1-10-4). Compounds 2 (10.0 mg, 0.0062%), 1 (2.0 mg, 0.0012%), 10 (3.2 mg, 0.002%), 9 (10.2 mg, 0.0063%), and 8 (30.0 mg, 0.0186%) were obtained from subfraction ACEW10-1 using preparative TLC (silica gel, n-hexane-Me 2 CO, 15:1). Compounds 13 (7.0 mg, 0.0043%), 14 (6.1 mg, 0.0038%), and 15 (3.5 mg, 0.0022%) were isolated from subfraction ACEW10-3 by column chromatography over silica gel using n-hexane-EtOAc (1:1) as the eluent. Subfraction ACEW10-4 was chromatographed on a silica gel column using n-hexane-EtOAc (1:1.5) as the eluent to yield compound 3 (3.0 mg, 0.0019%).
The n-hexane layer (9.3 g) was chromatographed on silica gel and eluted with EtOAc in nhexane (gradient of 0-100% EtOAc) to obtain ten fractions. 
Results and discussion
The structural elucidation of the five newly isolated benzenoids, benzocamphorins A-E, (1-5) is described below. Compound 1 was isolated as a pale yellow oil. HRESIMS showed an [M + Na] + ion peak at m/z 285.0740, consistent with the molecular formula C 14 H 14 O 5 Na. The IR spectrum suggested that 1 was a benzenoid (ν max 1610, 1475, and 1446 cm −1 ) bearing a conjugated carbonyl (ν max 1663 cm −1 ). The latter was identified as a methyl ketone based on the carbon resonances at δ 33.2 (CH 3 ) and 184.8 (qC) as well as the proton resonance at δ 2.45 (3H, s). 6 The 1 H NMR spectra of 1 showed signals for one methylenedioxy [δ H 5.98 (2H, s)], one aromatic methyl [δ H 2.31 (3H, s)], and two methoxy [δ H 3.88 (3H, s) and 4.02 (3H, s)] groups. In addition, a 1,2-disubstituted alkyne [δ C 87.6 (qC) and 96.0 (qC)] was also observed in the 13 C NMR spectrum of 1. The above characteristic NMR signals were similar to those of the known benzenoid antrocamphin B (10), isolated from the same organism. 6 Detailed inspection of the HMBC spectrum of 1 led to the assignment of a 3-oxobut-1-ynyl group (Figure 2) . The NOE correlations between Me-4 and OMe-5 and between Me-3′ and the methylenedioxy protons helped to establish the structure of 1 (Figure 6 ).
The molecular formula of 2, C 15 H 16 O 4 , was established from HRESIMS and 13 C NMR spectroscopic data. The IR spectrum showed absorption bands attributable to a benzonoid at ν max 1611, 1473, and 1449 cm −1 . The 1 H NMR spectrum of 2 was similar to that of 1, except that the 3-oxobut-1-ynyl group in 1 was replaced by a 3-methylbut-3-en-1-ynyl group in 2. This assignment was enforced by the presence of the proton resonances for a 1,1-disubstituted double bond at δ 5.36 (1H, s) and 5.25 (1H, s), which correlated to C-2′, C-3′, and C-4′ in the HMBC spectrum of 2. In the NOESY spectrum of 2, a NOE correlation between the methylenedioxy proton and the Me-3′ protons suggested that the methylenedioxy group was located at C-1 and C-2. In addition, the Me-4 protons showed NOE correlations with one proton of the sp 2 methylene group at δ 5.36 and with the OMe-5 protons at δ 3.85, which suggested that Me-4 was adjacent to C-3 and C-5. The locations of all functionalities borne by the benzene ring were thus determined. The above characteristic NMR signals were similar to those of the known compound, methyl 2,5-dimethoxy-3,4-methylenedioxybenzoate (6), 7 suggesting an isomeric relationship between both compounds. The aromatic methine proton showed an HMBC correlation with the carbonyl carbon of the methyl ester and an NOE correlation with the methoxy protons at C-5, suggesting that this proton (H-6) was located between C-1 and C-5. Considering the above evidence coupled with a comparison of the NMR spectroscopic data of 3 with those of 6, the structure of 3 was thus determined as methyl 4,5-dimethoxy-2,3-methylenedioxybenzoate.
Compound 4 was isolated as a white powder and exhibited a [M + Na] + peak at m/z 399.1051, corresponding to the molecular formula of C 19 H 20 O 8 Na and ten degrees of unsaturation. Its IR spectrum showed absorption bands at 1619, 1497, 1489, 1448, and 1427 cm −1 , disclosing that 4 is a benzenoid. Its 1 H NMR spectrum, coupled with a HMQC experiment, showed signals for two methylenedioxy groups at δ 5.98 and 5.94, three methoxy groups at δ 3.93, 3.88, and 3.82, and two aromatic methyl groups at δ 2.06 and 2.03. One remaining aromatic methine and eleven aromatic quaternary carbons were also observed in the 13 C NMR spectrum of 4. Thus, 4 might be a benzoic dimer. In subunit A, the HMBC correlations from the methyl proton at δ H 2.06 to the carbons at C-1′, C-2′, and C-6′, from the methylenedioxy protons at δ H 5.98 to the carbons at C-3′ and C-4′, and from the phenyl proton at δ H 5.92 (H-6′) to the carbons at C-1′, C-2′, C-4′ and C-5′ (Figure 2 ) in combination with selective 1D NOESY experiments (Me-1′ / OMe-2′, Me-1′ / H-6′, and OMe-2′ / methylenedioxy protons at δ H 5.85) (Figure 7 ) enforced the locations of all functional groups on the benzene ring. The carbons in subunit B were deduced as a benzenoid containing a methyl, one methylenedioxy, and two methoxy substituents. The HMBC correlations from Me-1 protons to C-2 and C-6 carbons as well as the selective 1D NOESY enhancements of Me-1 /OMe-2, H-6′ / Me-1 and H-6′ / OMe-5 established the structure of subunit B. Based on the carbon resonances of C-6 and C-5′ at 139.5 and 137.25, respectively, the two subunits were connected by an oxygen atom, which also was consistent with the molecular formula of 4.
The HRESIMS spectrum of 5 disclosed that it possesses a molecular ion peak at m/z 385.0897, corresponding to the molecular formula C 18 showed HMBC correlations to C-1, C-2, and C-6, suggesting that this methyl group was positioned between C-2 and C-6, to which the other molecular half was attached. In the NOESY spectrum of 5 (Figure 7 ), the methylenedioxy protons showed an NOE correlation with the OMe-2 carbon, suggesting that this substituent was positioned at C-3 and C-4. Thus, the one remaining hydroxy group should be positioned at C-5. The structure of 5 was unambiguously determined as shown in Figure 1 .
The structural characterization of ten newly isolated triterpenoids, camphoratins A-J (16-25), was reported previously in Ref 13 . In addition, 23 known compounds were identified by the comparison of their physical and spectroscopic data with those of corresponding authentic samples, including seven benzenoids [2,5-dimethoxy-3,4-methylenedioxybenzoate (6), 7 2,2′,5,5′-tetramethoxy-3,4,3′,4′-bi-methylenedioxy-6,6'-dimethylbiphenyl (7), 8 4,7-dimethoxy-5-methyl-1,3-benzodioxole (8), 8 antrocamphins A and B (9 and 10), 6 syringic acid (11), 9 and 3,4,5-trimethoxybenzoic acid (12)], 10 three lignans [4-hydroxysesamin (13), 11 (+) sesamin (14), 11 and aptosimon (15)], 12 and 13 triterpenoids [zhankuic acids A-C (26-28), 14, 15 zhankuic acid A methyl ester (29), 14 antcin A (30), 15 antcin C (31), 15 antcin K (32), 16 methyl antcinate H (33), 17 eburicol (34), 18 ergosterol D (35), 19 methyl 4α-methylergost-8,24(28)-dien-3,11-dion-26-oate (36), 20 ergosterol peroxide (37), 21 and ergosta-2,4,8(14),22-tetraen-3-one (38)]. 22 Compounds 7-9, 13, 14, 20, 21, 25-33, and 36 were first assayed for cytotoxic activity against Doay (human medulloblastoma), Hep2 (human laryngeal carcinoma), MCF-7 (human breast adenocarcinoma), and Hela (human cervical epitheloid carcinoma) cell lines. Compounds 9 and 21 showed moderate cytotoxicity against MCF-7 and Hep2 cell lines with ED 50 values of 3.4 and 3.0 µg/mL, respectively ( Table 1) . The other tested compounds showed marginal or little cytotoxicity (threshold for activity is considered 4 µg/mL) against the above cancer cell lines.
The anti-inflammatory effects of 2, 7-9, 17, 21, and 24-37 were then evaluated by examining their effects on lipopolysaccharide (LPS)-induced iNOS-dependent NO production and NADPH oxidase (NOX)-dependent reactive oxygen species (ROS) production in BV2 murine microglial cells and polymorphonuclear neutrophils (PMNs) ( Table 2 ). Triterpenoids 21, 25, 26, 29-31, 33 , and 36 inhibited NOS activity significantly with IC 50 values of 2.5, 1.6, 3.6, 0.6, 4.1, 4.2, 2.5, and 1.5 µM, respectively. They were more potent than N-nitro-L-arginine methyl ester (L-NAME) (IC 50 : 25.8 µM), a nonspecific NOS inhibitor, at inhibiting LPS-induced NO production. Except for 8 and 35, the remaining tested compounds also effectively inhibited NOS activity with IC 50 values ranging from 6.3 to 22.3 µM. NOX is the major ROS-producing enzyme in activated inflammatory cells. 23 We previously reported that drugs with anti-inflammatory activity also show potent NOX-inhibitory action.24 ,25 Therefore, we evaluated the isolates for effects on NOX activity in lysates of microglial cells and PMNs. Our data suggest that none of the tested compounds were potent inhibitors of NOX, relative to the specific NOX inhibitor diphenyleneiodonium (DPI) (IC 50 0.4 and 0.3 µM in lysates of microglial cells and PMNs, respectively) ( Table 2) .
Based on an overview of the biological data, the following structure-activity relationship (SAR) conclusions were noted regarding the NOS inhibitory activity for compounds 17, 21, and 24-37 (Table 2) . Among the tested compounds, the 3-ketone triterpenoids were more active than the corresponding 3-hydroxy analogues (e.q., 21 vs 17; 27 vs 16). Similarly, introduction of a hydroxy group to C-4 resulted in a dramatic loss of activity (e.q., 27 vs 32). It is apparent that a less polar A ring contributed to increased activity. In addition, comparison of triterpenoids with different substituents at C-7 revealed that the rank order of potency was 7-ketone (29) > 7-methylene (30) ≈ 7-hydroxy (31). On the other hand, compound 25, the rare example with a 14β-hydrogen configuration, was less potent than the normal triterpene (29, 14α-hydrogen). A comparison of the carboxylic acids and methyl carboxylates revealed that the latter were slightly more potent than the former (e.g., 21 vs 31; 29 vs 26). Consequently, the most active 29 could be reasonably explained by the fact that it possesses 7-ketone, less polar A ring, and methyl carboxylate functionalities.
In conclusion, the results from the anti-inflammatory assays revealed that the triterpenoids 21, 25, 26, 29-31, 33, and 36 have potent NO-reducing activity in microglial cells. Thus, triterpenoids rather than benzenoids might be the active components of the folk remedy using T. camphoratus for the treatment of some inflammatory related disorders. However, continued investigation of related triterpernoids coupled with structure modification studies could be helpful to develop and optimize lead chemotherapeutic agents.
Experimental

General experimental procedures
Melting points were determined on a Yanagimoto MP-S3 micro-melting point apparatus. IR spectra were recorded on a Shimadzu FTIR spectrometer Prestige-21. Optical rotations were measured using a Jasco DIP-370 polarimeter. UV spectra were obtained on a Hitachi UV-3210 spectrophotometer. ESI and HRESI mass spectra were recorded on a Bruker APEX II mass spectrometer. The NMR spectra, including 1 H NMR, 13 C NMR, COSY, NOESY, HMBC, HMQC experiments, were recorded on Bruker AVANCE-500 and AMX-400. Silica gel (E. Merck 70-230, 230-400 mesh) was used for column chromatography. NOE correlations of 4 and 5. 
